Presentations at SOT 2023

9:00-10:45 a.m. – Tox Expo Hall C

Abstract 3015/Poster P116: Development and Validation of Enzyme-Based CYP26A1 Inhibition Assay in a High-Throughput Screening Platform
Authors: Sakamuru S, Ma D, Pierro JD, Baker NC, Kleinstreuer N, Cali JJ, Knudsen TB, Xia M

9:00-10:45 a.m. – Tox Expo Hall C

Abstract 3161/Poster P270: In Vitro Assessment of Environmental Chemical Hazards on Cardiovascular Diseases
Authors: Ramaiahgari S, Krishna S, Kleinstreuer N, Liu J, Auerbach SS, Beverly B, Merrick BA, Berridge BR

9:00-10:45 a.m. – Tox Expo Hall C

Abstract 3175/Poster P290: An Informatics Approach to Inform a Class-Based Analysis of Health Effects Associated with Exposure to Organohalogen Flame Retardants
Authors: Rooney AA, Mansouri K, Bevington C, Hatlelid K, Helmick K, Blain R, Hannani A, Tracy W, Peppriell A, Cooney G, Sibrizzi C, Taylor K, Shipkowski K, Walker V

Abstract 3177/Poster P292: Evaluation of Skin Sensitization Classification Rules to Reflect Human Potency
Authors: Herzler M, Abedini J, To KT, Allen DG, Api AM, Germolec D, Gordon J, Kleinstreuer NC, Ko H, Matheson J, Thierse H, Truax J, Vanselow J, Strickland J

Abstract 3181/Poster P296: Evaluating New Chemicals in the US under the Toxic Substances Control Act: Application of New Approach Methods to Evaluate Eye Irritation
Authors: Beardslee RA, Salazar KD, van der Zalm A, Camacho IA, Brunner R, Raabe H, Allen D, Daniel A, Kleinstreuer NC, O'Dell L, Clippinger A, Scarano L, Lowit A

9:15 a.m.-12:00 noon – Karl Dean Ballroom B1

Abstract 1016: Computational Crowdsourcing to Understand and Address Regulatory Needs: Case Studies for Prioritization of Environmental Chemicals Using AI/ML Approach
Author: Kleinstreuer N

9:15 a.m.-12:00 noon – Room 207B

Kamel Mansouri (NIEHS/NICEATM) is session chair.

Presentation: Introduction
Author: Mansouri K

Abstract 1053: Applications of Class-Based Approaches in Risk Assessment and Toxicological Research
Author: Mansouri K

10:45 a.m.-12:30 p.m. – Tox Expo Hall C

Abstract 3137/Poster P245: Three-Phase Testing of Agrochemical Formulations: Developing a Defined Approach for Eye Irritation Potential
Authors: Daniel AB, van der Zalm AJ, Clippinger AJ, Kleinstreuer NC, Allen DG

10:45 a.m.-12:30 p.m. – Tox Expo Hall C

Abstract 3271/Poster P390: Mechanistic Insights from Profiling Chemical-Mediated Transcription Factor Transactivation with the Integration of Cytochrome P450 Metabolism
Authors: Medvedev A, Karmaus AL, Hull V, Reinke EN, Daniel AB, Allen DG, Kleinstreuer NC, Casey W

1:45-4:30 p.m. – Room 202

Abstract 1094: Human Biological Relevance: Topical Toxicity Case Studies
Author: Kleinstreuer N

2:30-4:15 p.m. – Tox Expo Hall C

Agnes Karmaus (Inotiv, contractor supporting NICEATM) is session chair.

Abstract 3064/Poster P169: OPERA Models Supporting Regulatory Needs
Authors: Mansouri K, Martin T, Chang X, Williams A, Kleinstreuer N

Abstract 3068/Poster P173: Interpretable Chemical Grouping Using an Automated KNIME Workflow
Authors: Moreira Filho J, Conway M, Schmitt C, Kleinstreuer N, Mansouri K

Abstract 3089/Poster P194: DASS App: A Web Application for Applying Defined Approaches for Skin Sensitization to Predict Hazard and Potency Categorization
Authors: To KT, Strickland J, Borrel A, Truax J, Allen DG, Kleinstreuer NC

9:00-10:45 a.m. – Tox Expo Hall C

Abstract 3669/Poster P154: Combining NAM Data and IVIVE for Evaluating Potential Inhalation Toxicity
Authors: Chang X, Reinke EN, Daniel AB, Allen DG, Mumtaz MM, Kleinstreuer NC

Abstract 3670/Poster P155: Integrating Population Enzyme Variability into Physiologically Based Kinetic Models of Parent Chemicals and Metabolites
Authors: Hull V, Hines D, Unnikrishnan A, Karmaus AL, Allen DG, Dorne JC, Erickson J, Combs P, Ferguson S, Kleinstreuer NC, Mansouri K

Abstract 3695/Poster P180: Annotations for ToxCast and Tox21 High-Throughput Screening Assays: Facilitating Assay Interpretation and Data Use
Authors: Karmaus AL, Borrel A, Feshuk M, Harrill A, Wittwehr C, Kleinstreuer NC

1:00-2:30 p.m. – Room 202

Agnes Karmaus (Inotiv, contractor supporting NICEATM) is session chair.

Abstract 1139: Leveraging In Vivo Variability to Assess Performance of Predictive Models and the Role of Reanalysis to Build Confidence via Consensus
Authors: Karmaus AL

2:30-4:15 p.m. – Tox Expo Hall C

Abstract 3624/Poster P106: Validation of the Electrophilic Allergen Screening Assay (EASA) to Detect Substances That Impact the Initial Key Event in the Adverse Outcome Pathway for Skin Sensitization
Authors: Gordon J, Truax J, Borrel A, Reinke EN, Adams V, Rua D, Petersen E, Uhl R, Allen DG, Kleinstreuer NC, Strickland J

Abstract 3627/Poster P109: Application of Defined Approaches for Skin Sensitization for Chemicals of Federal Agency Interest
Authors: Strickland J, Truax J, To KT, Reinke EN, Gulledge T, Johnson VJ, Allen DG, Kleinstreuer NC, Germolec D

Abstract 3634/Poster P116: Peer Review Report of the EpiSensA Skin Sensitization Assay
Authors: Reinke EN, Corsini E, Ono A, Fukuyama T, Ashikaga T, Gerberick GF

Abstract 3643/Poster P125: Methods2AOP: An International Collaboration to Integrate Assay Annotations into the AOP Key Event Descriptions
Authors: Wittwehr C, Chang X, Bisson W, Edwards SW, Ferguson S, Harrill A, Hogberg HT, Karmaus AL, Batista-Leite S, Lekka E, Kleinstreuer NC, Markey KJ, Masci AM, Mennecozzi M, Mortensen HM, O'Brien JM, Reinke EN, Schmitt C, Tucker NN, Virvilis V

2:30-4:15 p.m. – Tox Expo Hall C

Abstract 3740/Poster P226: Applying In Silico Toxicity Models across the Tox21 Chemical Universe
Authors: Lee S, Borrel A, To KT, Li T, Liu Z, Tong W, Benfenati E, Roncaglioni A, Manganaro A, Mansouri K, Kleinstreuer NC

Abstract 3742/Poster P228: ChemMaps.com V2: Exploring the Environmental Chemical Universe
Authors: Borrel A, Unnikrishnan A, Allen DG, Kleinstreuer NC

Abstract 3744/Poster P230: Integrated Chemical Environment: An Advanced Platform Aiding NAM-Based Chemical Assessments
Authors: Unnikrishnan A, Karmaus AL, Hull V, Chang X, Borrel A, To KT, Daniel AB, Cooper S, Phillips J, McAfee E, Allen DG, Casey W, Kleinstreuer NC

2:30-4:15 p.m. – Tox Expo Hall C

Abstract 4009/Poster P504: The Adverse Outcome Pathway Framework Applied to Neurological Symptoms of COVID-19
Authors: Hogberg-Durdock H, Lam A, Elan O, Shahbaz MA, Clerbaux L, Bal-Price A, Coecke S, Concha R, De Bernardi F, Edrosa E, Hargreaves AJ, Kanninen KM, Munoz A, Pistollato F, Saravanan S, Garcia-Reyero N, Wittwehr C, Sachana M

3:00-4:30 p.m. – Room 205

Abstract 2039: Mapping a Path to Disease: Quantifying the Risk of Exposure to Environmental Chemical Mixtures via a Common Molecular Target Using a Geospatial Modeling Approach
Authors: Eccles KM, Karmaus AL, Kleinstreuer NC, Parham F, Wambaugh JF, Messier KP

3:00-4:30 p.m. – Room 202

Kim To (Inotiv, contractor supporting NICEATM) is session co-chair.

8:00-10:45 a.m. – Karl Dean Ballroom A1

NICEATM staff scientist Helena Hogberg-Durdock is session chair.

Presentation: Introduction
Author: Hogberg-Durdock H

9:00-10:45 a.m. – Tox Expo Hall C

Abstract 4326/Poster P191: Risk-Based, Geospatially Informed Prioritization of Potentially Cardiotoxic Chemicals
Authors: Krishna S, Chang X, Eccles KM, Messier K, Kleinstreuer NC

10:45 a.m.-12:30 p.m. – Tox Expo Hall C

Abstract 4449/Poster P322: Parallel Evaluation of Alternative Skin Barrier Models and Excised Human Skin for Dermal Absorption Studies In Vitro
Authors: Salminen AT, Davis KJ, Felton RP, Nischal N, VonTungeln LS, Beland FA, Derr K, Brown PC, Ferrer M, Katz LM, Kleinstreuer NC, Leshin J, Manga P, Sadrieh N, Xia M, Fitzpatrick SC, Camacho L

Abstract 4454/Poster P327: The Skin Allergy Risk Assessment-Integrated Chemical Environment (SARA-ICE) Model for UN GHS Classification: An Evaluation and Application in Case Studies
Authors: Reynolds G, Reynolds J, Gilmour N, Strickland J, Reinke E, Germolec D, Truax J, Allen D, Maxwell G, Kleinstreuer N

1:30-4:15 p.m. – Room 205

Abstract 1240: The Central Role of Computational Toxicology in Toxicology 2.0
Authors: Kleinstreuer NC

9:00-10:45 a.m. – Tox Expo Hall C

Abstract 3005/Poster P106: Lessons Learned in Establishing a Reliable and Low-Cost Assay for Urea Production in Human Primary Hepatocytes Cultured in a Liver Chip for the Study of Drug Hepatotoxicity
Authors: Shi Q, Ren L, Papineau KS, Sauld J, Kulkarni G, Ewart L, Avigan M, Mendrick DL, JJ Hawes, Schnackenberg LK

Abstract 3010/Poster P111: Adaptive versus Toxicological Responses: Reversibility for DILI with 3D Hepatocyte Transcriptomics
Authors: Ferguson SS, Lavrich K, Ramaiahgari S, Auerbach S, Phadke D, Balik-Meisner M, Shah R, Roberts G, Gorospe J, Sparrow B, DeVito M, Paules RS, Alex M

9:00-10:45 a.m. – Tox Expo Hall C

Abstract 3150/Poster P259: Inhalation of Emissions Generated by 3D Print with Polycarbonate Plastic: Cardiovascular Effects
Authors: Krajnak K, Farcas M, McKinney W, Waugh S, Mandler W, Matheson J, Thomas T, Qian Y

9:00-10:45 a.m. – Tox Expo Hall C

Abstract 3175/Poster P290: An Informatics Approach to Inform a Class-Based Analysis of Health Effects Associated with Exposure to Organohalogen Flame Retardants
Authors: Rooney AA, Mansouri K, Bevington C, Hatlelid K, Helmick K, Blain R, Hannani A, Tracy W, Peppriell A, Cooney G, Sibrizzi C, Taylor K, Shipkowski K, Walker V

Abstract 3177/Poster P292: Evaluation of Skin Sensitization Classification Rules to Reflect Human Potency
Authors: Herzler M, Abedini J, To KT, Allen DG, Api AM, Germolec D, Gordon J, Kleinstreuer NC, Ko H, Matheson J, Thierse H, Truax J, Vanselow J, Strickland J

Abstract 3178/Poster P293: Evaluating New Chemicals in the US under the Toxic Substances Control Act (TSCA): A Human Health Risk Assessment Approach for Mixed Metal Oxides (MMOs) in Cathode Active Materials (CAMs) Used in Electric Vehicle (EV) Batteries
Authors: Salazar KD, Beardslee RA, Scarano L, Lowit A

Abstract 3181/Poster P296: Evaluating New Chemicals in the US under the Toxic Substances Control Act: Application of New Approach Methods to Evaluate Eye Irritation
Authors: Beardslee RA, Salazar KD, van der Zalm A, Camacho IA, Brunner R, Raabe H, Allen D, Daniel A, Kleinstreuer NC, O'Dell L, Clippinger A, Scarano L, Lowit A

10:45 a.m.-12:30 p.m. – Tox Expo Hall C

Abstract 3226/Poster P343: Evaluation of Newly Developed 14 Human TK6-Derived Cell Lines That Individually Express a Human Cytochrome P450 for Toxicity Studies
Authors: Mei N, Li X, Le Y, Guo X, Manjanatha MG, Chen S, Guo L

Abstract 3229/Poster P346: Actein Contributes to Black Cohosh Extract-Induced Genotoxicity in Human TK6 Cells
Authors: Le Y, Li S, Chen S, Ning K, Guo X, Wu C, Manjanatha M, Mei N

10:45 a.m.-12:30 p.m. – Tox Expo Hall C

Abstract 3271/Poster P390: Mechanistic Insights from Profiling Chemical-Mediated Transcription Factor Transactivation with the Integration of Cytochrome P450 Metabolism
Authors: Medvedev A, Karmaus AL, Hull V, Reinke EN, Daniel AB, Allen DG, Kleinstreuer NC, Casey W

12 noon-1:00 p.m. – Room 101D – Presented by LabCorp

Monique Perron (ICCVAM workgroup member, EPA) is a member of the presenting panel.

12:10-1:30 p.m. – Room 207B

Cecilia Tan (ICCVAM representative, EPA) will moderate the panel discussion.

12:10-1:30 p.m. – Karl Dean Ballroom A1

Presentation: A US EPA Regulatory Perspective to Molecular Points of Departure
Author: Lowit A

1:45-4:30 p.m. – Karl Dean Ballroom A1

Presentation: Introduction
Author: Hatlelid K

1:45-4:30 p.m. – Room 202

Abstract 1098: Practical Steps to Putting the Scientific Confidence Framework into Regulatory Use
Author: Lowit A

2:30-4:15 p.m. – Tox Expo Hall C

Abstract 3063/Poster P168: Machine Learning Models for Rat Multigeneration Reproductive Toxicity Prediction
Authors: Liu J, Guo W, Dong F, Aungst J, Fitzpatrick S, Patterson TA, Hong H

Abstract 3086/Poster P191: MetSim: Integrated Programmatic Access and Pathway Management for Xenobiotic Metabolism Simulation Tools
Authors: Groff LK, Hagan B, Patlewicz G, Shah I

2:30-4:15 p.m. – Tox Expo Hall C

Abstract 3279/Poster P400: Environmental Metal Mixtures Exposure Prevalence in Pregnant Women in the United States
Authors: Ruiz P, Cheng P, Desai S, Shin M, Jarrett JM, Ward CD, Shim Y

Abstract 3280/Poster P401: Real-Life Environmental Exposures and Neurodegenerative Diseases
Authors: Jameshenry N, Pulido H, Ruiz P, Mumtaz M

Abstract 3289/Poster P410: Development of a Database to Derive Inhalation TTC Values for Airborne Compounds
Authors: Schwartz-Zocher M, Api AM, Joshi K, Giusti A, Rose J, Collins S, Patlewicz G, Bowden AM, Boisleve F, Singal M, Sadekar N, Escher SE

Abstract 3298/Poster P419: Assessing Audiology Studies for Various Ototoxic Substances
Authors: Bradley M, Zarus G, Ruiz P, Eichwald J

9:00-10:45 a.m. – Tox Expo Hall C

Abstract 3669/Poster P154: Combining NAM Data and IVIVE for Evaluating Potential Inhalation Toxicity
Authors: Chang X, Reinke EN, Daniel AB, Allen DG, Mumtaz MM, Kleinstreuer NC

9:00-10:45 a.m. – Tox Expo Hall C

Abstract 4207/Poster P717: Optimizing Circadian Transcriptional Machinery Output to Augment Cellular Resiliency in Operationally Extreme Environments
Authors: Cox C, Hussain S, Kemp M

11:00 a.m.-12:30 p.m. – Karl Dean Ballroom A1

Suzanne Fitzpatrick (ICCVAM principal agency representative, FDA) is session chair

Presentation: What Are Regulators Looking For?
Author: Fitzpatrick S

1:00-2:15 p.m. – Room 201

Abstract 2033: Deriving Benchmark Dose from the Deep-Learning Prediction Scores of High-Throughput Toxicology Images
Authors: Tandon A, Howard BE, Mav D, Balik-Meisner M, Ramaiaghari S, Ferguson S, Shah R, Merrick BA

2:30-4:15 p.m. – Tox Expo Hall C

Abstract 3620/Poster P102: Evaluating Acrylamide Toxicokinetics in an In Vitro Integrated Organ Platform
Authors: McKim JM, Austin D, Sprando RL, Mattes W, Fitzpatrick S

Abstract 3624/Poster P106: Validation of the Electrophilic Allergen Screening Assay (EASA) to Detect Substances That Impact the Initial Key Event in the Adverse Outcome Pathway for Skin Sensitization
Authors: Gordon J, Truax J, Borrel A, Reinke EN, Adams V, Rua D, Petersen E, Uhl R, Allen DG, Kleinstreuer NC, Strickland J

Abstract 3625/Poster P117: Analysis of Reproducibility and Robustness of PhysioMimix™ T12, a Proximal Renal Tubule Microphysiological System for Studies of Pharmacokinetics and Toxicological Assessment of Drugs and Chemicals
Authors: Sakolish C, Moyer H, Ferguson SS, Chiu WA, Rusyn I

Abstract 3626/Poster P108: A Novel Approach to Investigate the Molecular Interaction between Inhaled Contaminants and the Human Lung Surfactant System
Authors: Mayville B, Coyle J, Sayes C, Hussain S

2:30-4:15 p.m. – Tox Expo Hall C

Abstract 3656/Poster P140: Reproducibility and Robustness of PhysioMimix LC12, a Liver Microphysiological System, under Varying Culture Conditions and Cell Type Combinations
Authors: Lim AY, Kato Y, Sakolish C, Hardwick RN, Ferguson SS, Rusyn I

Abstract 3664/Poster P148: Comparative Analysis of Tox21 In Vitro Assay Readouts from Three Major Data-Cleaning Pipelines
Authors: Sedykh A, Kidd B, Gombar V, Shah R, Casey W

2:30-4:15 p.m. – Tox Expo Hall C

Abstract 3966/Poster P460: High-Throughput Phenotypic Profiling Approach for the Screening and Prioritization of Potential Developmental Neurotoxicity Hazard
Authors: Culbreth M, Byrd G, Harris F, Willis C, Carstens K, Harrill JA

2:30-4:15 p.m. – Tox Expo Hall C

Abstract 3744/Poster P230: Integrated Chemical Environment: An Advanced Platform Aiding NAM-Based Chemical Assessments
Authors: Unnikrishnan A, Karmaus AL, Hull V, Chang X, Borrel A, To KT, Daniel AB, Cooper S, Phillips J, McAfee E, Allen DG, Casey W, Kleinstreuer NC

2:30-4:15 p.m. – Tox Expo Hall C

Abstract 3986/Poster P480: Evaluation of Per- and Polyfluoroalkyl Substances (PFAS) In Vitro Toxicity Testing for Developmental Neurotoxicity
Authors: Carstens K, Freudenrich T, Wallace K, Choo S, Carpenter A, Patlewicz G, Richard A, Wetmore B, Paul Friedman K, Shafer T

2:30-4:15 p.m. – Tox Expo Hall C

Abstract 4009/Poster P504: The Adverse Outcome Pathway Framework Applied to Neurological Symptoms of COVID-19
Authors: Hogberg-Durdock H, Lam A, Elan O, Shahbaz MA, Clerbaux L, Bal-Price A, Coecke S, Concha R, De Bernardi F, Edrosa E, Hargreaves AJ, Kanninen KM, Munoz A, Pistollato F, Saravanan S, Garcia-Reyero N, Wittwehr C, Sachana M

9:00-10:45 a.m. – Karl Dean Ballroom A1

Abstract 1207: Diversity Outbred Mice That Mimic Human Heterozygosity and Are Highly Genetically Diverse
Author: Harrill A

9:00-10:45 a.m. – Tox Expo Hall C

Abstract 4321/Poster P186: Utilizing a Pharmacokinetic Model for Evaluating Exposures to PFOA: Various Dosing Considerations Aimed at Simulating Site-Specific Exposures to Drinking Water
Authors: Welsh C, Sautner J, Siwakoti R, Compton J, Kowalski P, Goodwin B, Somers TS, Ruiz P, Fisher J

9:00-10:45 a.m. – Tox Expo Hall C

Abstract 4494/Poster P369: Mixtures Risk Assessment of Volatile Organic Chemicals through Multiple Target Organ Evaluation
Authors: Mumtaz MM, Young A, Mellard D, Pohl H, Przybyla J, Langmann D

10:45 a.m.-12:30 p.m. – Tox Expo Hall C

Abstract 4288/Poster P152: An In Vitro 3D Model of the Human Renal Proximal Tubule for Nephrotoxicity Screening Studies
Authors: Pearson AT, Travlos GS, Ferguson SS

10:45 a.m.-12:30 p.m. – Tox Expo Hall C

Abstract 4369/Poster P236: Biological Response Similarity Analyses and Hierarchical Clustering of Aqueous Film-Forming Foams (AFFF) and Perfluoroalkyl and Polyfluoroalkyl Substances (PFAS) Using In Vitro Hepatocyte Transcriptomics
Authors: Mauge-Lewis KA, Ramaiahgari S, Roberts G, Waidyanatha S, Fenton S, Phadke D, Balik-Meisner M, Ferguson S, Gorospe J, Sparrow B

10:45 a.m.-12:30 p.m. – Tox Expo Hall C

Abstract 4437/Poster P309: Pulmonary Evaluation of Whole-Body Inhalation Exposure of Polycarbonate (PC) Filament 3D Printer Emissions in Rats
Authors: Farcas MT, McKinney W, Mandler W, Knapp A, Service S, Battelli L, Friend SA, Leboul R, Thomas TA, Matheson JA, Qian Y

10:45 a.m.-12:30 p.m. – Tox Expo Hall C

Abstract 4449/Poster P322: Parallel Evaluation of Alternative Skin Barrier Models and Excised Human Skin for Dermal Absorption Studies In Vitro
Authors: Salminen AT, Davis KJ, Felton RP, Nischal N, VonTungeln LS, Beland FA, Derr K, Brown PC, Ferrer M, Katz LM, Kleinstreuer NC, Leshin J, Manga P, Sadrieh N, Xia M, Fitzpatrick SC, Camacho L

Abstract 4452/Poster P325: Development of Preliminary Candidate Surface Guidelines for Air Force-Relevant Dermal Sensitizers Using New Approach Methodologies
Authors: Keebaugh AJ, Clewell RA, Steele ML, Raabe H, Merrill EA, Chusha YG, Cantrell K, Islas-Robles A, Hillberer A, Mattie DR

10:45 a.m.-12:30 p.m. – Tox Expo Hall C

Abstract 4739/Poster P646: Investigation of Blue Cohosh Extract Compositions and Human Hepatocellular Effects
Authors: Quiroz-Delfi G, Mueller G, Jarmusch AK, Ferguson SS, Rider CK

11:00 a.m.-12:20 p.m. – Room 209

Presentation: Use of NAMs to Meet Regulatory Needs: Scoping Opportunities in a New Paradigm
Author: Perron M

1:30-4:15 p.m. – Karl Dean Ballroom A1

Abstract 1254: Regulatory Perspectives on the Integration of Novel Testing Tools, Such as MPS and CIVM, into Nonclinical Drug Safety Assessment
Author: N Sadrieh

2:30-4:15 p.m. – Tox Expo Hall C

Abstract 4274/Poster P137: Unraveling PCB Effects in Differentiated Human Hepatocytes
Authors: Dunlap PE, Rice JR, Ramaiahgari S, Dunnick J, Merrick BA, DeVito MJ, Ferguson SS

2:30-4:15 p.m. – Tox Expo Hall C

Abstract 4583/Poster P473: Weight-of-Evidence Analysis for the Development of a Reference List of Chemical Respiratory Sensitizers
Authors: Carstens K, Freudenrich T, Wallace K, Choo S, Carpenter A, Patlewicz G, Richard A, Wetmore B, Paul Friedman K, Shafer T

8:30-11:15 a.m. – Room 202

Allison Harrill (ICCVAM representative, EPA) is session chair.

Presentation: Introduction
Author: Harrill A

8:30-11:15 a.m. – Room 207B

Abstract 1268: Introduction to Inhalation Risk Assessment and Initial NAM Considerations
Author: Perron M